PharmaTimesNews & Politicsnews

Erasca secures FDA fast track for eras‑0015 in pancreatic cancer

Thursday, August 27, 2026John PinchingView original

Designation supports rapid development of pan‑RAS molecular glue

Read the full article on the original site.

Read Full Article